Talks of earlier-than-expected bond tapering in the US spooked the local markets, with the ASX 200 index down by 0.28% today.

Overnight, the S&P 500 fell by 1.9% as US Fed Chairman Jerome Powell flagged the need to speed up the bond tapering program at the December meeting.

Speaking in a testimony before the US Senate, Powell said that “it’s now appropriate to consider speeding up the taper of the central bank’s asset purchases”.

He’s also revised the Fed’s previous messaging, saying it isn’t applicable anymore to describe today’s inflation as transitory, and that it’s “a good time to retire that word”.

The only ASX sectors in the green today were the Miners, which rose by 0.5% ,and Healthcare, which was up by 0.15%.

Energy stocks were relatively subdued despite global oil prices plunging to the lowest levels in three months ahead of the Opec+ meeting on Thursday (US time).

In economics data news, Australia’s national accounts released this morning showed GDP contracted less than feared.

A contraction of 2.7% had been tipped but the result was a modest 1.9% retreat – paling in comparison to the record 6.8% drop in the June quarter last year – and on an annualised basis, the economy was 3.9% bigger.

Meanwhile, Australian housing prices grew for the 14th month in a row – by 1.3%. However the rate of growth had slowed to levels not seen since January.

BIG CAP WINNERS

Swipe or scroll to reveal the full table. Click headings to sort.

Code Name Price % Change Volume Market Cap
S32 South32 Limited 3.68 4.2% 16,430,898 $16,462,733,620
ABB Aussie Broadband 5.45 4.2% 1,102,679 $1,170,641,104
CRN Coronado Global Res 1.14 3.6% 1,680,406 $1,844,099,103
FCL Fineos Corp Hold PLC 4.56 3.6% 95,112 $1,403,304,153
SDR Siteminder 6.54 3.5% 449,906 $1,707,934,496
XRO Xero Ltd 149.28 3.1% 296,625 $21,542,722,506
LYC Lynas Rare Earths 9.13 2.9% 4,073,792 $8,004,390,484
WPR Waypoint REIT 2.64 2.7% 5,267,949 $1,875,628,526
APX Appen Limited 9.84 2.6% 1,153,952 $1,180,288,444
OZL OZ Minerals 26.65 2.5% 1,131,327 $8,671,692,748
RIO Rio Tinto Limited 95.80 2.5% 941,915 $34,708,716,009
GNC GrainCorp Limited 6.96 2.4% 1,378,489 $1,556,218,270
IRE IRESS Limited 12.68 2.3% 440,027 $2,354,625,621
ILU Iluka Resources 8.80 2.1% 1,574,249 $3,648,004,188

AngloGold Ashanti (ASX:AGG) rose after announcing that a new auditor PriceWaterHouse Coopers will replace Ernst & Young as part of the mandatory auditor rotation.

Aussie Broadband (ASX:ABB), FINEOS (ASX:FCL), and Lynas Rare Earths (ASX:LYC) all rose by 3-4% on no specific news.

BIG CAP LOSERS

Swipe or scroll to reveal the full table. Click headings to sort.

Code Name Price % Change Volume Market Cap
IMU Imugene Limited 0.505 -8.2% 20,979,644 $3,139,193,361
PME Pro Medicus Limited 58 -7.2% 220,138 $6,522,056,836
GUD G.U.D. Holdings 10.84 -7.1% 2,475,956 $1,141,130,396
PDN Paladin Energy Ltd 0.885 -6.3% 18,498,214 $2,531,503,774
IEL Idp Education Ltd 32.9 -5.9% 2,069,633 $9,736,200,661
ASM Ausstratmaterials 12.55 -5.8% 423,174 $1,858,220,000
CHN Chalice Mining Ltd 9.43 -5.4% 1,802,093 $3,531,754,655
SYA Sayona Mining Ltd 0.1425 -5.0% 46,613,856 $1,056,750,070
DUB Dubber Corp Ltd 3.4 -4.8% 1,453,567 $1,066,948,303
JHG Janus Henderson 59.85 -4.5% 101,042 $1,835,480,427
IPL Incitec Pivot 3.06 -4.4% 9,386,239 $6,215,120,093
AMP AMP Limited 0.99 -4.3% 25,899,679 $3,380,419,558
AEF Australian Ethical 13.95 -4.3% 188,676 $1,638,604,472
CTT Cettire 3.65 -4.2% 609,930 $1,452,517,618
PRU Perseus Mining Ltd 1.575 -4.0% 5,861,090 $2,012,476,095

Nuix (ASX:NXL) and Sezzle (ASX:SZL) touched record lows today.

Yesterday, Nuix held its AGM just a few days before the first anniversary of its listing.

The drama at Nuix this year has sparked the departure of CEO Rod Vawdrey, CFO Stephen Doyle and co-founder Anthony Castagna.

On top of all this, the company’s sales were hit by the extended transition of government in the US, and COVID-19 impacts on customers.

Telix Pharma (ASX:TLX) also fell today despite reporting that Illucix has been granted exceptional authorisation for prostate cancer imaging in Brazil.

This authorisation grants permission to commence selling Illuccix in Brazil, ahead of a full regulatory approval, expected next year.